European Market Open: Higher start ahead of Brexit vote
Joshua Warner December 30, 2020 3:16 PM
UK politicians are set to vote on the Brexit deal later today, while the country has also become the first to approve the AstraZeneca-Oxford university vaccine.
FTSE 100 to open higher
The FTSE 100 is set to open 0.3% higher at 6610.5 after ending at 6589.9 yesterday. The index briefly touched its highest level since March during yesterday’s session before giving back most of those gains to end the day slightly higher.
European indices set for positive start
The Euro STOXX Index is called to open 0.2% higher at 3576.5 from 3568.7 at the end of play on Tuesday.
France’s CAC 40 is called to open 0.3% higher at 5607.0 from 5588.0 at the last close.
Germany’s DAX is set to open 0.2% higher at 13755.5 from 13730.4. The index reached its highest level since early February in yesterday’s session before falling back to the end the day higher.
UK MPs to vote on Brexit deal
Parliament is being recalled today to allow MPs to vote on the Brexit deal, formally named the EU (future relationship) Bill. Politicians have been given little time to evaluate the deal that was announced late on December 24, but it is widely expected to be approved thanks to the Conservative government’s large majority and the opposition Labour party’s support.
UK prime minister Boris Johnson is expected to say in a speech today ahead of the vote that the deal allows the country to take control of its laws but also to maintain a close friendship with the bloc.
On the other side of the Channel, EU ambassadors have already provisionally approved the deal and will formally ratify it sometime in January.
UK prepares for tougher coronavirus restrictions
The UK government will conduct its latest review of the tiered restrictions in place today to stop the spread of coronavirus. UK cases have climbed to new record highs and there are now more people being treated for the virus in hospital than ever before.
Swathes of the country were placed into the strictest tier 4 restrictions on December 26 and more places are expected to be placed under the strictest rules within the next few days. Some reports suggest new, harsher restrictions could be introduced in the worst-hit areas. Health secretary Matt Hancock is due to speak to the House of Commons about the findings of the review this afternoon.
UK approves AstraZeneca-Oxford university vaccine
The UK medicines regulator this morning approved the coronavirus vaccine developed by AstraZeneca and Oxford university. It is the second vaccine to be approved by the UK after the Pfizer-BioNTech was given the green light earlier this year.
The vaccine is expected to offer major advantages due to its low cost and because it can be stored and transported easier than the Pfizer-BioNTech one, which needs to be stored at very low temperatures. The UK has bought 100 million doses of the vaccine and the jab should start to be rolled-out early in 2021.
Forex: EUR/USD hits 8-month high
GBP/USD traded at 1.35432 this morning, up 0.3% from 1.35033 at the end of play yesterday.
EUR/USD was also up 0.3% at 1.22829 – its highest level since April - from 1.22414 at the last close.
Meanwhile, EUR/GBP traded broadly flat at 0.90694 from 0.90717.
Commodities: Oil and gold both rise
Brent traded at $51.42 in early morning trade, up from $51.17 at yesterday’s close, while WTI followed higher to $48.26 from $48.12.
Gold traded at $1881 this morning from $1878 yesterday.
Market-moving events in the economic calendar
Today’s economic calendar sees the KOF Swiss leading indicator at 0800 GMT and Swiss ZEW survey at 0900 GMT. This afternoon sees the US Chicago PMI at 1445 GMT and pending home sales at 1500 GMT.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.
Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.